Wednesday, November 15, 2017 5:32:56 PM
JANUARY 16, 2009
The DEA called ElSohly, who spent December 13 and 14, 2005, defending his monopoly. His testimony was revealing. Much of his work for the government involves testing the potency of thousands of marijuana samples seized by law enforcement agencies throughout the country. On his own time, presumably, he has patented a THC-extract suppository, which a corporation called Insys is trying to market. El Sohly also has a contract with Mallinckrodt, a giant chemical company that plans to market a THC-extract pill as an alternative to Marinol (which is synthetic THC in prescribable pill form).
InSys makes a drug called Subsys which kils people. Developed Syndros (oral THC liquid that around 80% bypasses first pass effect). They said no to ElSohly. Nothing happened with Mallinchkrodt either. Why?
I think they need to come clean...
Who are the two (2) investors who funded the Series F round?
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM